Information  X 
Enter a valid email address

Uniphar PLC (UPR)

  Print      Mail a friend

Friday 24 April, 2020

Uniphar PLC

Notice of AGM and Annual Report

RNS Number : 7152K
Uniphar PLC
24 April 2020




Publication of Notice of Annual General Meeting and Annual Report



Dublin, London | 24 April 2020



Uniphar plc (the "Company" or "Uniphar") wishes to announce that it is today posting to shareholders its Notice of Annual General Meeting ("AGM") for 2020 together with its annual report and accounts for the year ended 31 December 2019 ("Annual Report"). The AGM will be held at 11am on 26 May 2020 at Uniphar's registered office, 4045 Kingswood Road, Citywest Business Park, Dublin 24, D24 V06K.


Uniphar considers the well-being of shareholders, employees and attendees a top priority. Based on the latest available guidance from the Health Service Executive ("HSE") in Ireland, the board of directors of Uniphar (the "Board") expect the AGM to proceed on 26 May 2020 but under very constrained circumstances.


In line with the measures advised by the HSE and Irish Governments restrictions on public gatherings, the Board have put in place a number of measures to minimise the risk of spreading the Coronavirus (COVID-19) at the AGM and encourage all shareholders, on this occasion, to refrain from attending the AGM in person and to complete and return their Proxy Forms as soon as possible to ensure their vote is registered at the AGM.


Given the severity of the circumstances and the health risks involved, Uniphar's directors will take all appropriate safety measures to ensure the safety of attendees and others involved in the AGM, including restricting attendance at the AGM, should it be deemed necessary or desirable.


Proxy voting can be carried out in advance of the AGM in one of the following ways: (1) by completing the Proxy Form enclosed with the Notice of AGM, (2) via the registrar's website at or (3) via the CREST electronic proxy appointment service for those shareholders who are CREST members.


Shareholders may submit questions relating to the business of the meeting in advance (so as to be received by no later than 5 p.m. on Friday, 22 May 2020) by email to the Company Secretary, Aisling McCarthy, at [email protected]   or by post to the Company's registered office, marked for the attention of the Company Secretary.


For the convenience and safety of shareholders, the AGM will be conducted over a live conference call and shareholders may register to receive participant log-in details at using the conference ID 7495818. The conference call facility is a listening facility only and shareholders will not be able to vote or ask questions via the conference call facility.


The Board encourages shareholders to check Regulatory Information Services and the Company's website for any updates in relation to the AGM. Shareholders are also encouraged to keep up-to-date with Government announcements and to follow HSE/World Health Organization guidance.


An electronic copy of the Notice of AGM and Annual Report are available on the Company's website at  




--- ENDS ---





For further details contact:




Brian O'Shaughnessy

Group Director of Corporate Development


+353 (0) 1 428 7777



[email protected]




(Nominated Adviser and Euronext Growth Adviser) 


Fergal Meegan

Barry Murphy

Tom Tynan


+353 (0) 1 679 6363


About Uniphar plc


Headquartered in Dublin, Ireland, Uniphar is an international diversified healthcare services business servicing the requirements of more than 200 multinational pharmaceutical and medical technology manufacturers across three divisions - Commercial & Clinical, Product Access and Supply Chain & Retail. With a workforce of more than 2,200, the Group is active in Ireland, the UK, the Benelux, the Nordics and the US.


The Company's vision is to improve patient access to pharmaco-medical products and treatments by enhancing connectivity between manufacturers and healthcare stakeholders. Uniphar represents a strong combination of scale, growth and profitability.


Commercial & Clinical  

In Commercial & Clinical the Group provides sales, marketing & distribution solutions to multinational pharmaceutical and medical device manufacturers on an outsourced basis. Active in Ireland, the UK, the Benelux and the Nordics, the Group is growing with clients to provide pan-European solutions. Uniphar have built a fully integrated multi-channel solution that is supported by highly experienced, clinically trained teams to deliver exceptional outcomes for all clients.



Product Access  

In Product Access the Group is growing two distinct service offerings: 1) "On-Demand Access", which are pharmacy led solutions for sourcing and supplying unlicensed medicines to meet the needs of both retail and hospital pharmacists; and 2) "Exclusive Access", which are manufacturer led solutions for controlling the release of speciality medicines for specifically approved patient populations in agreed markets. The Group currently delivers product access solutions to more than 160 markets globally.


Supply Chain & Retail  

Uniphar is an established market leader in Ireland with c50% supply chain market share supported by a network of 287 owned, franchised and symbol group pharmacies. The business supports the diverse customer base through the provision of strong service levels coupled with innovative commercial initiatives. Supply Chain & Retail is an Irish only business for the Group, although the assets and infrastructure are utilised for the benefit of the growth divisions.


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit

a d v e r t i s e m e n t